The World Health Organisation (WHO) said it's updating its guidelines on COVID-19 treatment to reflect the trial results of a common steroid in critical COVID-19 cases.
The preliminary results showed that dexamethasone reduced death rates by about one third for critically ill patients.
"This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in a statement.
The agency said it will "coordinate a meta-analysis to increase our overall understanding of this intervention" and update the guidelines to "reflect how and when the drug should be used in COVID-19".
The drug has been used since the 1960s to reduce inflammation in diseases such as arthritis.
Trump calls for expanded deportation efforts of undocumented immigrants
Israel and Iran strike at each other in new wave of attacks
2 killed, 25 swept away after bridge collapses in India's Pune
Gunman who shot 2 US lawmakers still at large as manhunt continues
Israeli fire kills 12 people in Gaza, medics say
Helicopter crashes in northern Indian state, 6 people on board
India orders inspection of Boeing 787s after Air India crash
Iran launches waves of missiles at Israel in response to airstrikes
